PCRX
Pacira BioSciences, Inc.$25.34-0.21 (-0.82%)Prev Close$25.55·MCap$1.09B·P/E172.99·Vol173.1K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
14
$3.10M
◆
Net Activity
Net Seller
$3.10M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Pacira BioSciences, Inc. (PCRX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 14 insider sales totaling $3.10M. The most recent insider transaction was by Cross Shawn (officer: Chief Financial Officer), who sold $325.6K worth of shares on Apr 24, 2026. Pacira BioSciences, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $1.09B.
PCRX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | Cross Shawn | officer: Chief Financial Officer | Sell | 12,941 | $25.16 | $325.6K | 105,341 |
| Apr 22, 2026 | Cross Shawn | officer: Chief Financial Officer | Sell | 9,214 | $25.12 | $231.4K | 105,341 |
| Mar 19, 2026 | Froimson Mark | director | Sell | 500 | $21.81 | $10.9K | 20,136 |
| Mar 19, 2026 | SLONIN JONATHAN | officer: Chief Medical Officer | Sell | 3,261 | $22.82 | $74.4K | 223,640 |
| Feb 3, 2026 | RIKER LAUREN | officer: Senior Vice President, Finance | Sell | 4,000 | $20.81 | $83.2K | 52,313 |
| Jan 30, 2026 | Teehan Brendan | Chief Commercial Officer | Sell | 5,182 | $20.54 | $106.4K | 0 |
| Jan 30, 2026 | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 30,271 | $20.54 | $621.6K | 0 |
| Jan 2, 2026 | Lee Frank D. | Chief Executive Officer | Sell | 9,272 | $24.46 | $226.8K | 0 |
| Jan 2, 2026 | RIKER LAUREN | Senior Vice President, Finance | Sell | 1,575 | $24.26 | $38.2K | 0 |
| Dec 9, 2025 | Cross Shawn | Chief Financial Officer | Sell | 25,000 | $25.07 | $626.8K | 0 |
| Nov 10, 2025 | Cross Shawn | Chief Financial Officer | Sell | 12,060 | $22.09 | $266.4K | 0 |
| Aug 7, 2025 | BIGAL MARCELO | Director | Sell | 4,912 | $23.67 | $116.3K | 0 |
| Jun 3, 2025 | RIKER LAUREN | Senior Vice President, Finance | Sell | 8,952 | $26.28 | $235.3K | 0 |
| Jun 3, 2025 | SLONIN JONATHAN | Chief Medical Officer | Sell | 5,084 | $26.40 | $134.2K | 0 |
| Jan 6, 2025 | SLONIN JONATHAN | Chief Medical Officer | Sell | 879 | $18.40 | $16.2K | 93,444 |
| Dec 16, 2024 | GAUGLER DARYL | Chief Operating Officer | Sell | 500 | $19.76 | $9.9K | 115,200 |
| Sep 13, 2024 | GAUGLER DARYL | Chief Operating Officer | Sell | 500 | $12.86 | $6.4K | 115,700 |
| Aug 19, 2024 | BIGAL MARCELO | Director | Buy | 1,512 | $13.25 | $20.0K | 10,142 |
| Aug 19, 2024 | Brege Laura | Director | Buy | 1,000 | $12.81 | $12.8K | 17,552 |
| Aug 14, 2024 | YANG MICHAEL J. | Director | Buy | 2,000 | $12.90 | $25.8K | 7,230+38% |
| Aug 13, 2024 | Lee Frank D. | Chief Executive Officer | Buy | 8,264 | $12.10 | $100.0K | 107,784 |
| Aug 12, 2024 | BIGAL MARCELO | Director | Buy | 3,400 | $12.01 | $40.8K | 8,630+65% |
| Aug 12, 2024 | Froimson Mark | Director | Buy | 1,400 | $11.58 | $16.2K | 14,473 |
| Aug 2, 2024 | SLONIN JONATHAN | Chief Medical Officer | Sell | 945 | $20.05 | $18.9K | 94,307 |
| Jul 3, 2024 | SLONIN JONATHAN | Chief Medical Officer | Sell | 2,836 | $28.25 | $80.1K | 95,557 |
| Jun 13, 2024 | GAUGLER DARYL | Chief Operating Officer | Sell | 1,000 | $28.38 | $28.4K | 116,040 |
| Jun 13, 2024 | HASTINGS PAUL J | Director | Sell | 880 | $28.38 | $25.0K | 12,724 |
| Jun 13, 2024 | RIKER LAUREN | Senior Vice President, Finance | Sell | 3,970 | $28.72 | $114.0K | 38,075 |
| Jun 13, 2024 | SLONIN JONATHAN | Chief Medical Officer | Sell | 5,012 | $28.57 | $143.2K | 44,569 |
| Jun 13, 2024 | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 7,452 | $28.38 | $211.5K | 102,912 |
| Mar 8, 2024 | PACE GARY W | Director | Sell | 119,323 | $30.64 | $3.66M | 140,384-46% |
| Aug 4, 2023 | WINSTON ROY | Chief Medical Officer | Sell | 509 | $34.88 | $17.8K | 52,440 |
| Jul 7, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | Sell | 643 | $38.91 | $25.0K | 22,687 |
| Jun 16, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | Sell | 6,366 | $38.42 | $244.6K | 28,467 |
| Jun 16, 2023 | Williams Kristen Marie | Chief Administrative Officer | Sell | 6,467 | $37.03 | $239.5K | 25,375 |
| Jun 12, 2023 | Kronenfeld Mark A. | Director | Sell | 15,000 | $37.04 | $555.6K | 17,897-46% |
| Jun 7, 2023 | Brege Laura | Director | Sell | 600 | $38.74 | $23.2K | 9,547 |
| Jun 7, 2023 | Ellis Ronald J. Jr. | Chief Strategy Officer | Sell | 2,276 | $38.42 | $87.4K | 32,071 |
| Jun 7, 2023 | GAUGLER DARYL | Chief Operating Officer | Sell | 3,052 | $38.52 | $117.6K | 23,591 |
| Jun 7, 2023 | HASTINGS PAUL J | Director | Sell | 580 | $38.34 | $22.2K | 6,599 |
| Jun 7, 2023 | McLoughlin Dennis | Chief Customer Officer | Sell | 2,071 | $38.42 | $79.6K | 39,172 |
| Jun 7, 2023 | MOLLOY ANTHONY | Chief Lgl & Compliance Officer | Sell | 6,788 | $38.46 | $261.1K | 17,398-28% |
| Jun 7, 2023 | REINHARDT MAX | President, Rest of World | Sell | 2,153 | $38.42 | $82.7K | 30,324 |
| Jun 7, 2023 | Reinhart Charles A. III | Chief Financial Officer | Sell | 2,607 | $38.40 | $100.1K | 34,997 |
| Jun 7, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | Sell | 1,207 | $38.42 | $46.4K | 19,669 |
| Jun 7, 2023 | SLONIN JONATHAN | Chief Clinical Officer | Sell | 961 | $38.42 | $36.9K | 36,813 |
| Jun 7, 2023 | STACK DAVID M | CEO and Chairman | Sell | 10,384 | $38.41 | $398.9K | 159,107 |
| Jun 7, 2023 | Williams Kristen Marie | Chief Administrative Officer | Sell | 2,658 | $38.42 | $102.1K | 22,249 |
| Jun 7, 2023 | WINSTON ROY | Chief Medical Officer | Sell | 3,636 | $38.42 | $139.7K | 43,213 |
| Jun 2, 2023 | GAUGLER DARYL | Chief Operating Officer | Sell | 2,500 | $39.08 | $97.7K | 24,591 |
Showing 1–50 of 109
1 / 3
PCRX Insider Buying Activity
The following table shows recent insider purchases of Pacira BioSciences, Inc. (PCRX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | BIGAL MARCELO | Director | Buy | 1,512 | $13.25 | $20.0K | 10,142 |
| Aug 19, 2024 | Brege Laura | Director | Buy | 1,000 | $12.81 | $12.8K | 17,552 |
| Aug 14, 2024 | YANG MICHAEL J. | Director | Buy | 2,000 | $12.90 | $25.8K | 7,230+38% |
| Aug 13, 2024 | Lee Frank D. | Chief Executive Officer | Buy | 8,264 | $12.10 | $100.0K | 107,784 |
| Aug 12, 2024 | BIGAL MARCELO | Director | Buy | 3,400 | $12.01 | $40.8K | 8,630+65% |
| Aug 12, 2024 | Froimson Mark | Director | Buy | 1,400 | $11.58 | $16.2K | 14,473 |
PCRX Insider Selling Activity
The following table shows recent insider sales of Pacira BioSciences, Inc. (PCRX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | Cross Shawn | officer: Chief Financial Officer | Sell | 12,941 | $25.16 | $325.6K | 105,341 |
| Apr 22, 2026 | Cross Shawn | officer: Chief Financial Officer | Sell | 9,214 | $25.12 | $231.4K | 105,341 |
| Mar 19, 2026 | Froimson Mark | director | Sell | 500 | $21.81 | $10.9K | 20,136 |
| Mar 19, 2026 | SLONIN JONATHAN | officer: Chief Medical Officer | Sell | 3,261 | $22.82 | $74.4K | 223,640 |
| Feb 3, 2026 | RIKER LAUREN | officer: Senior Vice President, Finance | Sell | 4,000 | $20.81 | $83.2K | 52,313 |
| Jan 30, 2026 | Teehan Brendan | Chief Commercial Officer | Sell | 5,182 | $20.54 | $106.4K | 0 |
| Jan 30, 2026 | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 30,271 | $20.54 | $621.6K | 0 |
| Jan 2, 2026 | Lee Frank D. | Chief Executive Officer | Sell | 9,272 | $24.46 | $226.8K | 0 |
| Jan 2, 2026 | RIKER LAUREN | Senior Vice President, Finance | Sell | 1,575 | $24.26 | $38.2K | 0 |
| Dec 9, 2025 | Cross Shawn | Chief Financial Officer | Sell | 25,000 | $25.07 | $626.8K | 0 |
| Nov 10, 2025 | Cross Shawn | Chief Financial Officer | Sell | 12,060 | $22.09 | $266.4K | 0 |
| Aug 7, 2025 | BIGAL MARCELO | Director | Sell | 4,912 | $23.67 | $116.3K | 0 |
| Jun 3, 2025 | RIKER LAUREN | Senior Vice President, Finance | Sell | 8,952 | $26.28 | $235.3K | 0 |
| Jun 3, 2025 | SLONIN JONATHAN | Chief Medical Officer | Sell | 5,084 | $26.40 | $134.2K | 0 |
| Jan 6, 2025 | SLONIN JONATHAN | Chief Medical Officer | Sell | 879 | $18.40 | $16.2K | 93,444 |
| Dec 16, 2024 | GAUGLER DARYL | Chief Operating Officer | Sell | 500 | $19.76 | $9.9K | 115,200 |
| Sep 13, 2024 | GAUGLER DARYL | Chief Operating Officer | Sell | 500 | $12.86 | $6.4K | 115,700 |
| Aug 2, 2024 | SLONIN JONATHAN | Chief Medical Officer | Sell | 945 | $20.05 | $18.9K | 94,307 |
| Jul 3, 2024 | SLONIN JONATHAN | Chief Medical Officer | Sell | 2,836 | $28.25 | $80.1K | 95,557 |
| Jun 13, 2024 | GAUGLER DARYL | Chief Operating Officer | Sell | 1,000 | $28.38 | $28.4K | 116,040 |
| Jun 13, 2024 | HASTINGS PAUL J | Director | Sell | 880 | $28.38 | $25.0K | 12,724 |
| Jun 13, 2024 | RIKER LAUREN | Senior Vice President, Finance | Sell | 3,970 | $28.72 | $114.0K | 38,075 |
| Jun 13, 2024 | SLONIN JONATHAN | Chief Medical Officer | Sell | 5,012 | $28.57 | $143.2K | 44,569 |
| Jun 13, 2024 | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 7,452 | $28.38 | $211.5K | 102,912 |
| Mar 8, 2024 | PACE GARY W | Director | Sell | 119,323 | $30.64 | $3.66M | 140,384-46% |
| Aug 4, 2023 | WINSTON ROY | Chief Medical Officer | Sell | 509 | $34.88 | $17.8K | 52,440 |
| Jul 7, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | Sell | 643 | $38.91 | $25.0K | 22,687 |
| Jun 16, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | Sell | 6,366 | $38.42 | $244.6K | 28,467 |
| Jun 16, 2023 | Williams Kristen Marie | Chief Administrative Officer | Sell | 6,467 | $37.03 | $239.5K | 25,375 |
| Jun 12, 2023 | Kronenfeld Mark A. | Director | Sell | 15,000 | $37.04 | $555.6K | 17,897-46% |
| Jun 7, 2023 | Brege Laura | Director | Sell | 600 | $38.74 | $23.2K | 9,547 |
| Jun 7, 2023 | Ellis Ronald J. Jr. | Chief Strategy Officer | Sell | 2,276 | $38.42 | $87.4K | 32,071 |
| Jun 7, 2023 | GAUGLER DARYL | Chief Operating Officer | Sell | 3,052 | $38.52 | $117.6K | 23,591 |
| Jun 7, 2023 | HASTINGS PAUL J | Director | Sell | 580 | $38.34 | $22.2K | 6,599 |
| Jun 7, 2023 | McLoughlin Dennis | Chief Customer Officer | Sell | 2,071 | $38.42 | $79.6K | 39,172 |
| Jun 7, 2023 | MOLLOY ANTHONY | Chief Lgl & Compliance Officer | Sell | 6,788 | $38.46 | $261.1K | 17,398-28% |
| Jun 7, 2023 | REINHARDT MAX | President, Rest of World | Sell | 2,153 | $38.42 | $82.7K | 30,324 |
| Jun 7, 2023 | Reinhart Charles A. III | Chief Financial Officer | Sell | 2,607 | $38.40 | $100.1K | 34,997 |
| Jun 7, 2023 | Riker Lauren Bullaro | Senior Vice President, Finance | Sell | 1,207 | $38.42 | $46.4K | 19,669 |
| Jun 7, 2023 | SLONIN JONATHAN | Chief Clinical Officer | Sell | 961 | $38.42 | $36.9K | 36,813 |
| Jun 7, 2023 | STACK DAVID M | CEO and Chairman | Sell | 10,384 | $38.41 | $398.9K | 159,107 |
| Jun 7, 2023 | Williams Kristen Marie | Chief Administrative Officer | Sell | 2,658 | $38.42 | $102.1K | 22,249 |
| Jun 7, 2023 | WINSTON ROY | Chief Medical Officer | Sell | 3,636 | $38.42 | $139.7K | 43,213 |
| Jun 2, 2023 | GAUGLER DARYL | Chief Operating Officer | Sell | 2,500 | $39.08 | $97.7K | 24,591 |
PCRX Insiders
Similar Stocks to PCRX
ZTS
Zoetis Inc.
$117.12-0.61%
$51.80B
VTRS
Viatris Inc.
$14.73-0.51%
$17.15B
NBIX
Neurocrine Biosciences, Inc.
$127.61-0.36%
$13.07B
INDV
Indivior Pharmaceuticals Inc
$34.27-0.06%
$4.15B
SUPN
Supernus Pharmaceuticals, Inc.
$48.30-2.35%
$2.87B
PAHC
Phibro Animal Health Corporation
$53.96-3.88%
$2.19B
ANIP
ANI Pharmaceuticals, Inc.
$78.86-0.94%
$1.79B
PRGO
Perrigo Company plc
$11.63+1.25%
$1.61B